Monday, June 7, 2010

Female Sexual Desire Booster Drug To be Dicussed by FDA

Reproductive Health Drugs Advisory Committee of FDA is due to discuss the request made by Boehringer Ingelheim (A giant german pharmaceutical) to approve Flibanserin to increase libido in women. In pharmaceutical inductry the drug is known as female Viagra. Flibanserin, whose proposed names are Ectris and Girosa, may be the first of its kind medicine that stimulates and increases sex desire in females.

Desire of sex in women is outcome of more complex events than that of men. Apperently, Flibanserin won't work like viagra and it won't increase blood flow in female genital region. Flibanserin works by altering the chain of chemical reactions in the brain that finally result in increased sexual desire.

Unlike other proposed treatment such Intrinsa that releases testosterone through the skin into the blood, Flibanserin manipulates events of several reactions and that is why it is believed to be more effective.
Amy Allina, a member of National Women's Health Network, advocates the importance of such drug saying that sex life can be a problematic issue for some women in order to sustain healthy sex life and thereby happy marriage life.

Market of female viagra drug is estimated to be billions of dollars as its been more than 10 years since viagra was launched and no similar drug for females since then.

No comments:

Post a Comment